4.10

0.73% -0.03

After Hours: 4.10

Nanobiotix Adr (NBTX)

Overview News Price History Discussions Forecast

Nanobiotix Adr stock is traded at $4.10, with a volume of 6,644. It is down -0.73% in the last 24 hours and up +20.94% over the past month. Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

Previous Close:

$4.13

Open:

$4.17

24h Volume:

6,644

Relative Volume:

0.60

Market Cap:

$193.23M

Revenue:

$27,600

Net Income/Loss:

$-36.04M

P/E Ratio:

-5.1456

EPS:

-0.7968

Net Cash Flow:

$-1.66M

1W Performance:

+12.06%

1M Performance:

+20.94%

6M Performance:

+26.93%

1Y Performance:

-41.43%

1-Day Range:

$4.0615

$4.1831

1-Week Range:

$3.81

$4.20

52-Week Range:

$2.76

$7.29

Nanobiotix Adr Stock (NBTX) Company Profile

Name

Nanobiotix Adr

Sector

Healthcare (1178)

Industry

Biotechnology (671)

Phone

Address

Employee

108

Twitter

Next Earnings Date

2025-04-02

Latest SEC Filings

NBTX's Discussions on Twitter

Compare NBTX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
NBTX Nanobiotix Adr	4.10	173.44M	27,600	-36.04M	-1.66M	-0.7968
ONC Beone Medicines Ltd Adr	245.58	25.81B	3.81B	-644.79M	-669.77M	-6.24
VRTX Vertex Pharmaceuticals Inc	441.85	111.46B	11.10B	-988.90M	-1.26B	-3.92
AKTX Akari Therapeutics Plc Adr	1.35	40.37M	0	0	0	0.00
VRNA Verona Pharma Plc Adr	81.16	6.19B	0	-153.72M	-103.81M	-2.00
REGN Regeneron Pharmaceuticals Inc	489.52	64.44B	14.09B	4.50B	2.96B	39.28